Jyong Biotech (MENS)

• Market cap: $242M
• 1 day: -2.1%
• 5 days: -8.43%
• 1 month: -31.8%
• 3 months: -94.48%
• 6 months: -70.36%
• Year to date: -4.4%
• 1 year: -67.75%
• 5 years: -67.75%
• 10 years: -67.75%
• Sector: Healthcare
• Industry: Biotechnology

About: Jyong Biotech Ltd is a science-driven biotechnology company based in Taiwan and is committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia (primarily Taiwan and mainland China). It has been dedicated to the research and development of new drugs with high safety and efficacy. It has been developing a series of drug candidates, including one core drug candidate at NDA stage, one clinical-stage key drug candidate and other preclinical-stage drug candidates.